{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:42:20Z","timestamp":1792806140303,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04410-9","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:40:24Z","timestamp":1780659624000},"page":"5561-5569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-read sequencing bridges germline and somatic variant detection: a multi-modal approach for hereditary cancer diagnostics"],"prefix":"10.1007","volume":"28","author":[{"given":"Behich","family":"Koyutourk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4153-7739","authenticated-orcid":false,"given":"Havva","family":"\u00c7obano\u011fullar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mer","family":"Diker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polat","family":"Olgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya Demirta\u015f","family":"Esmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih M\u00fcjdat","family":"Balkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut Cerkez","family":"Ergoren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"8","key":"4410_CR1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/annonc\/mdz136","volume":"30","author":"D Mandelker","year":"2019","unstructured":"Mandelker D, Donoghue M, Talukdar S, Bandlamudi C, Srinivasan P, Vivek M, et al. Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group. Ann Oncol. 2019;30(8):1221\u201331.","journal-title":"Ann Oncol"},{"issue":"4","key":"4410_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.annonc.2022.01.006","volume":"33","author":"P Terraf","year":"2022","unstructured":"Terraf P, Pareja F, Brown DN, Ceyhan-Birsoy O, Misyura M, Rana S, et al. Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing. Ann Oncol. 2022;33(4):426\u201333.","journal-title":"Ann Oncol"},{"issue":"11","key":"4410_CR3","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1038\/s41375-021-01246-w","volume":"35","author":"D Singhal","year":"2021","unstructured":"Singhal D, Hahn CN, Feurstein S, Wee LYA, Moma L, Kutyna MM, et al. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer. Leuk. 2021;35(11):3245\u201356.","journal-title":"Leuk"},{"issue":"7","key":"4410_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/cancers16071275","volume":"16","author":"L Ermini","year":"2024","unstructured":"Ermini L, Driguez P. The application of long-read sequencing to cancer. Cancers (Basel). 2024;16(7):1275.","journal-title":"Cancers (Basel)"},{"issue":"8_Supplement_1","key":"4410_CR5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1158\/1538-7445.AM2025-710","volume":"85","author":"ES Seo","year":"2025","unstructured":"Seo ES, Moon JH, Park WY, Lee JW. Germline whole genome sequencing and nanopore long-read sequencing reveal high incidence of pathogenic variants in childhood cancer survivors with subsequent malignant neoplasms. Cancer Res. 2025;85(8_Supplement_1):710\u2013710.","journal-title":"Cancer Res"},{"issue":"4","key":"4410_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JC Wan","year":"2017","unstructured":"Wan JC, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017;17(4):223\u201338.","journal-title":"Nat Rev Cancer"},{"issue":"31","key":"4410_CR7","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","volume":"33","author":"ME Robson","year":"2015","unstructured":"Robson ME, Bradbury AR, Arun B, Domchek SM, Ford JM, Hampel HL, et al. American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2015;33(31):3660\u20137.","journal-title":"J Clin Oncol"},{"key":"4410_CR8","first-page":"1","volume":"17","author":"VC Cordeiro-de-lima","year":"2021","unstructured":"Cordeiro-de-lima VC, Ara\u00fajo LH, Garicochea B, Mano M, William WN, Lauda A, et al. Implementing somatic mutation testing in clinical setting: recommendations from a panel of experts. Braz J Oncol. 2021;17:1\u201344.","journal-title":"Braz J Oncol"},{"issue":"17","key":"4410_CR9","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1073\/pnas.1418631112","volume":"112","author":"A Belkadi","year":"2015","unstructured":"Belkadi A, Bolze A, Itan Y, Cobat A, Vincent QB, Antipenko A, et al. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants. Proc Natl Acad Sci USA. 2015;112(17):5473\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"4410_CR10","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41587-019-0217-9","volume":"37","author":"AM Wenger","year":"2019","unstructured":"Wenger AM, Peluso P, Rowell WJ, Chang PC, Hall RJ, Concepcion GT, et al. Accurate circular consensus long-read sequencing improves variant detection and assembly of a human genome. Nat Biotechnol. 2019;37(10):1155\u201362.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"4410_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41576-021-00367-3","volume":"22","author":"W De Coster","year":"2021","unstructured":"De Coster W, Weissensteiner MH, Sedlazeck FJ. Towards population-scale long-read sequencing. Nat Rev Genet. 2021;22(9):572\u201387.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"4410_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"6","key":"4410_CR13","first-page":"970","volume":"22","author":"SE Lincoln","year":"2020","unstructured":"Lincoln SE, Kobayashi Y, Anderson MJ, Yang S, Desmond AJ, Mills MA, et al. A systematic comparison of germline vs somatic variant classification in 48,000 tumors. Genet Med. 2020;22(6):970\u20138.","journal-title":"Genet Med"},{"key":"4410_CR14","first-page":"45","volume":"26","author":"M DeBortoli","year":"2025","unstructured":"DeBortoli M, Romanel A, Demichelis F. Integrating germline and somatic variant interpretation for precision oncology. Nat Rev Genet. 2025;26:45\u201359.","journal-title":"Nat Rev Genet"},{"key":"4410_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02151-8","volume":"21","author":"M Jain","year":"2020","unstructured":"Jain M, Olsen HE, Paten B, Akeson M. The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community. Genome Biol. 2020;21:239.","journal-title":"Genome Biol"},{"key":"4410_CR16","first-page":"112","volume":"43","author":"H Elrick","year":"2025","unstructured":"Elrick H, Tan RZ, Li H, Zhang Z, Ahmed R, Lau BT, et al. SAVANA: a novel long-read structural variant caller improves detection of clinically actionable alterations. Nat Biotechnol. 2025;43:112\u201320.","journal-title":"Nat Biotechnol"},{"key":"4410_CR17","first-page":"189","volume":"33","author":"L Savelyeva","year":"2024","unstructured":"Savelyeva L, Br\u00fcning T, Behnisch W, Mertens D, Schlegelberger B. Implementation of germline testing in hereditary cancer syndromes: lessons from large national cohorts. Cancer Epidemiol Biomarkers Prev. 2024;33:189\u201398.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"4410_CR18","first-page":"455","volume":"34","author":"ESMO Precision Medicine Working Group","year":"2023","unstructured":"ESMO Precision Medicine Working Group. Recommendations for the use of germline testing in cancer patients. Ann Oncol. 2023;34(4):455\u201365.","journal-title":"Ann Oncol"},{"key":"4410_CR19","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: genetic\/familial high-risk assessment. Version 2.2024."},{"key":"4410_CR20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41576-021-00367-3","volume":"22","author":"W De Coster","year":"2021","unstructured":"De Coster W, Weissensteiner MH, Sedlazeck FJ. Towards population-scale long-read sequencing. Nat Rev Genet. 2021;22:572\u201387.","journal-title":"Nat Rev Genet"},{"key":"4410_CR21","volume":"16","author":"HT Chan","year":"2024","unstructured":"Chan HT, Chin YM, Ngeow J, Li Y, Law KS. Clinical integration of liquid biopsy and long-read sequencing: opportunities and challenges. Cancers. 2024;16:2273.","journal-title":"Cancers"},{"key":"4410_CR22","volume":"15","author":"R Van Boxtel","year":"2025","unstructured":"Van Boxtel R, Cuppen E. Genomic technologies and precision oncology: the future of integrated diagnostics. Front Oncol. 2025;15:1053.","journal-title":"Front Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04410-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04410-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04410-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:02:15Z","timestamp":1792803735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04410-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["4410"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04410-9","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors do not have a conflict to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Near East University review board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (Approval Number YDU\/2022\/108-1658). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}